Literature DB >> 16554286

Inhaled anesthetic agents.

Joan Stachnik1.   

Abstract

PURPOSE: The pharmacology, bioavailability and pharmacokinetics, indications, clinical efficacy, adverse effects and toxicities, and dosage and administration of the inhaled anesthetics are reviewed.
SUMMARY: The inhaled anesthetics include desflurane, enflurane, halothane, isoflurane, and sevoflurane and are thought to enhance inhibitory postsynaptic channel activity and inhibit excitatory synaptic activity. The mechanism of action of inhaled anesthetics has not been completely defined. A number of factors can influence the pharmacokinetics of inhaled anesthetics, including solubility in blood, cardiac output, tissue equilibration, extent of tissue perfusion, metabolism, and age. All of the available inhaled anesthetics are effective for inducing or maintaining anesthesia or both. Most clinical trials of inhaled anesthetics have evaluated differences in induction and emergence from anesthesia by comparing (1) times to loss of reflex, extubation, and response to verbal commands; orientation to time and place; and ability to sit up without assistance, (2) need for post-surgical analgesia, and (3) time to discharge as measures of efficacy. Adverse effects and toxicities of the inhaled anesthetics include nephrotoxicity, hepatotoxicity, cardiac arrhythmias, neurotoxicity, postoperative nausea and vomiting, respiratory depression and irritation, malignant hyperthermia, and postanesthesia agitation. Safety issues surrounding these gases include occupational exposure and intraoperative fires within the delivery systems used with inhaled anesthetics. Drugs used for anesthesia during surgery can account for 5-13% of a hospital's drug budget.
CONCLUSION: The inhaled anesthetics have been shown to be both safe and effective in inducing and maintaining anesthesia. These agents differ in potency, adverse-effect profile, and cost. Newer anesthetic gases, such as sevoflurane and desflurane, appear to have more favorable physico-chemical properties. These factors, as well as patient characteristics and duration and type of procedure, must be considered when selecting an inhaled anesthetic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16554286     DOI: 10.2146/ajhp050460

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  19 in total

1.  Comparison of Traditional and Integrated Digital Anesthetic Vaporizers.

Authors:  Frederick W Damen; Amelia R Adelsperger; Katherine E Wilson; Craig J Goergen
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-11       Impact factor: 1.232

2.  Refractory Status Asthmaticus: Treatment With Sevoflurane.

Authors:  Lynn M Keenan; Terri L Hoffman
Journal:  Fed Pract       Date:  2019-10

3.  Isoflurane inhibits a Kir4.1/5.1-like conductance in neonatal rat brainstem astrocytes and recombinant Kir4.1/5.1 channels in a heterologous expression system.

Authors:  Mengchan Ou; Fu-Shan Kuo; Xinnian Chen; Uri Kahanovitch; Michelle L Olsen; Guizhi Du; Daniel K Mulkey
Journal:  J Neurophysiol       Date:  2020-07-29       Impact factor: 2.714

4.  Reduced respiratory neural activity elicits phrenic motor facilitation.

Authors:  Safraaz Mahamed; Kristi A Strey; Gordon S Mitchell; Tracy L Baker-Herman
Journal:  Respir Physiol Neurobiol       Date:  2010-12-15       Impact factor: 1.931

5.  Impact of remifentanil introduction on practice patterns in general anesthesia.

Authors:  Kanji Uchida; Hideo Yasunaga; Hiroaki Miyata; Masahiko Sumitani; Hiromasa Horiguchi; Ken Kuwajima; Shinya Matsuda; Yoshitsugu Yamada
Journal:  J Anesth       Date:  2011-09-09       Impact factor: 2.078

6.  The effect of sevoflurane and isoflurane anesthesia on single unit and local field potentials.

Authors:  Daniil P Aksenov; Michael J Miller; Conor J Dixon; Alice M Wyrwicz
Journal:  Exp Brain Res       Date:  2019-03-27       Impact factor: 1.972

7.  Brain tissue oxygen regulation in awake and anesthetized neonates.

Authors:  Daniil P Aksenov; Andrey V Dmitriev; Michael J Miller; Alice M Wyrwicz; Robert A Linsenmeier
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

8.  Pharmacologic Modulation of Noxious Stimulus-evoked Brain Activation in Cynomolgus Macaques Observed with Functional Neuroimaging.

Authors:  Tomomi Shirai; Mizuho Yano; Takahiro Natsume; YūJi Awaga; Yoshitaka Itani; Aldric Hama; Akihisa Matsuda; Hiroyuki Takamatsu
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-11-21       Impact factor: 1.232

9.  Interpreting Neuroendocrine Hormones, Corticosterone, and Blood Glucose to Assess the Wellbeing of Anesthetized Rats during Euthanasia.

Authors:  Debra L Hickman
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-10-10       Impact factor: 1.232

10.  Repeated exposure to modern volatile anaesthetics may cause chronic hepatitis as well as acute liver injury.

Authors:  Amanda Nicoll; David Moore; Dolores Njoku; Brad Hockey
Journal:  BMJ Case Rep       Date:  2012-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.